Indeed, there is a significant increase in RhoC, Cdc42 and MYL9 expression levels in metastasis versus primary tumours (Figure 6f), indicating that drivers of actomyosin contractility are selected during HCC metastatic dissemination. Here, MYL9 is linked to hepatocellular carcinoma.